Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Echinocandin antifungals: Review and update
Vicki A. Morrison
Medicine - Hematology, Oncology, Transplant
Research output
:
Contribution to journal
›
Review article
›
peer-review
90
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Echinocandin antifungals: Review and update'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Echinocandins
100%
Echinocandin Antifungal
100%
Esophagitis
75%
Caspofungin
50%
Anidulafungin
50%
Micafungin
50%
Candidemia
50%
Armamentarium
50%
Empirical Therapy
25%
Fungal Pathogens
25%
Immunocompromised Patients
25%
Fungal Infection
25%
Salvage Therapy
25%
Non-competitive Inhibition
25%
Febrile Neutropenia
25%
Antifungal Prophylaxis
25%
Fungal Cell Wall
25%
Antifungal Agents
25%
Aspergillus Infection
25%
Parenteral Formulation
25%
Combination Antifungal Therapy
25%
Oral Preparation
25%
3-glucan
25%
Hematopoietic Stem Cell Transplant Recipients
25%
Pharmacology, Toxicology and Pharmaceutical Science
Echinocandin
100%
Esophagus Candidiasis
60%
Micafungin
60%
Anidulafungin
60%
Antifungal Therapy
40%
Candidemia
40%
Caspofungin
40%
Infectious Agent
20%
Antifungal Agent
20%
Immunocompromised Patient
20%
Febrile Neutropenia
20%
Aspergillosis
20%
Glucan
20%